cbdMD, Inc. YCBD
Set alert
At close
Pre-market · Nov 3, 4:51 AM ET
- YTD
- -70.61%
- 1 year
- -54.66%
- Open
- 0.40
- Prev close
- 0.3827
- Mkt cap
- 4.45M
- Vol
- 297.49K
- Avg vol
- 392.15K
- EPS
- 0.23
- P/E
- 1.72
- Div yield
- 0.00%
More statistics
- Low
- 0.3721
- High
- 0.418
- Forward P/E
- -0.38
- Beta
- 1.99
- Short ratio
- 1.14
- Inst. own
- 3.33%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 11, 2025
- 50-d avg
- 0.46466
- 200-d avg
- 0.61418
- 1y target
- 2.00
2Y chart
Events in this range
- Dec 17, 2024Earnings: —; estimate 0; surprise —%
- Feb 11, 2025Earnings: —; estimate 0; surprise —%
- May 7, 2025Split: 1 for 8
Signals (76)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 21, 2026 | 1 week ago |
| RSI: Oversold | Oct 12, 2026 | 3 weeks ago |
| MACD: Sell Signal | Oct 5, 2026 | 4 weeks ago |
| MACD: Buy Signal | Sep 22, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 21, 2026 | 1 month ago |
| MACD: Buy Signal | Aug 25, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 18, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 4, 2026 | 3 months ago |
| RSI: Oversold | Jul 24, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 15, 2026 | 3 months ago |
| SMA: Bearish | Jul 13, 2026 | 3 months ago |
| SMA: Bullish | Jul 9, 2026 | 3 months ago |
| MACD: Buy Signal | Jun 25, 2026 | 4 months ago |
| SMA: Bearish | May 29, 2026 | 5 months ago |
| SMA: Bullish | May 28, 2026 | 5 months ago |
| SMA: Bearish | May 15, 2026 | 5 months ago |
| SMA: Bearish | May 7, 2026 | 5 months ago |
| SMA: Bullish | May 6, 2026 | 6 months ago |
| MACD: Sell Signal | May 5, 2026 | 6 months ago |
| SMA: Bearish | Apr 29, 2026 | 6 months ago |
Newest 20 of 76.
Key statistics
- Market cap
- 1.53M
- Enterprise value
- 3.22M
- Trailing P/E
- 0.00
- Forward P/E
- -0.38
- PEG ratio
- 0.00
- Price / sales
- 0.07
- Price / book
- 0.43
- EPS (TTM)
- -1.79
- Beta
- 1.99
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -94.12%
- Revenue (TTM)
- 20.64M
- Revenue growth
- -15.50%
- Free cash flow
- 4.69M
- Total cash
- 2.40M
- Total debt
- 4.11M
- Return on equity
- -135.07%
- Shares outstanding
- 4.47M
- Short % of float
- 4.74%
- 50-day average
- 0.46466
- 200-day average
- 0.61418
Analyst view
Consensus: none
Next earnings
Feb 11, 2025
Expected Feb 11, 2025. Consensus EPS estimate 0.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 11, 2025 | Dec 1, 2024 | 0.00 | — | — | — |
| Dec 17, 2024 | Sep 1, 2024 | 0.00 | — | — | — |
| Aug 14, 2024 | Jun 1, 2024 | 0.00 | -0.15 | — | — |
| May 15, 2024 | Mar 1, 2024 | 0.00 | -1.35 | — | — |
| Feb 13, 2024 | Dec 1, 2023 | 0.00 | -0.67 | — | — |
| Dec 22, 2023 | Sep 1, 2023 | 0.00 | -9.06 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 5, 2023 | Maxim Group | init | — | Buy |
About cbdMD, Inc.
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, and sleep, focus, and calming aids. The company also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name; nootropic mushroom line under the ATRx brand; and hemp derived solutions under the hempMD brand. It distributes its products through its e-commerce website, third-party e-commerce sites, select distributors and marketing partners, wholesalers, and various brick and mortar retailers in the United States. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is headquartered in Charlotte, North Carolina.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- United States
- Website
- cbdmd.com
News
Your note
Sign in to keep a note on YCBD — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| COFFMAN RAYMOND SCOTT | Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | Jan 10, 2024 | 0 |
| KENNEDY THOMAS RONAN | Chief Executive Officer | Purchase | May 2, 2023 | 6,462 |
| RAINES WILLIAM F III | Director | Stock Award(Grant) | Aug 22, 2024 | 84,256 |
| SELLERS BAKARI T | Director | Stock Award(Grant) | Mar 27, 2024 | 9,438 |
| STEPHEN SCOTT G | Director | Stock Award(Grant) | Mar 27, 2024 | 10,138 |
| SWIFT SIBYL NICHOLE | Director | Stock Award(Grant) | Mar 27, 2024 | 8,008 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Connective Capital Management LLC | 1.61% | 89,215 | 30.53K | Sep 29, 2024 |
| Two Sigma Securities, LLC | 0.40% | 22,066 | 7.55K | Sep 29, 2024 |
| Vanguard Group Inc | 0.24% | 13,042 | 4.46K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.20% | 11,195 | 3.83K | Sep 29, 2024 |
| Blackrock Inc. | 0.16% | 8,905 | 3.05K | Sep 29, 2024 |
| UBS Group AG | 0.06% | 3,176 | 1.09K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 0.24% | 13,042 | 4.46K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.16% | 8,992 | 3.08K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.02% | 1,124 | 384 | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.02% | 1,079 | 369 | Oct 30, 2024 |